Clovis Oncology (CLVS) Tops Q1 EPS by 11c

Clovis Oncology (NASDAQ: CLVS) reported Q1 EPS of ($1.63), $0.11 better than the analyst estimate of ($1.74). Revenue for the quarter came in at $33.12 million versus the consensus estimate of $32.24 million.

For earnings history and earnings-related data on Clovis Oncology (CLVS) click here.

You May Also Be Interested In

• Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
• Revelation Biosciences (REVB) Misses Q2 EPS by 4c
• Atlassian results seen as 'game changer' for AI kills software worries